Isolation and characterization of a new subtype A variant of human immunodeficiency virus type I from Nigeria

Tropical Medicine and International Health

Volumn 1, Issue 1, 1996, Pages 97-106

  Olaleye, D O ^a,b   Sheng, Zhijuan ^a   Howard, T M ^a   Rasheed, S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

AIDS; HIV 1 subtype A; Nigeria

Indexed keywords

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NIGERIA; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS TYPING;

ADULT; AMINO ACID SEQUENCE; BLOOD DONORS; CYTOPATHOGENIC EFFECT, VIRAL; DNA, VIRAL; HIV ENVELOPE PROTEIN GP120; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NIGERIA; SEROTYPING;

EID: 0030001812     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1996.d01-4.x     Document Type: Article

References (29)

1. Barin F, McLane MF, Allan JS et al. (1985) Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science 228, 1094-1096.
2. Cann AJ, Churcher MJ, Boyd M et al. (1992) The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. Journal of Virology 66, 305-309.
3. Cheng-Mayer C, Seto D, Tateno M & Levy J (1988) Biological features of HIV-1 that correlate with virulence in the host. Science 240, 80-82.
4. Cheng-Mayer C, Shioda T & Levy J (1991) Host range, replicative and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. Journal of Virology 65, 6931-6941.
5. Collman R, Balliet JW, Gregory SA et al. (1992) An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. Journal of Virology 66, 7517-7521.
6. Collman R, Hassan NF, Walker R et al. (1989) Infection of monocyte derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types. Journal of Experimental Medicine 170, 1149-1163.
7. Connor RI, Mohri H, Cao Y & Ho D (1993) Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1 infected individuals. Journal of Virology 67, 1772-1777.
8. Connor RI & Ho DD (1994) Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. Journal of Virology 68, 4400-44087.
9. Fenyo EM, Morfeldt-Manson L, Chiodi F et al. (1988) Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. Journal of Virology 62, 4414-4419.
10. Gu R, Westervelt P & Ratner L (1993) Role of HIV-1 envelope V3 loop cleavage in cell tropism. AIDS Research and Human Retroviruses 9, 1007-1015.
11. 1bNg) from Nigeria. AIDS Research and Human Retroviruses 10, 1755-1757.
12. Koot M, Vos AHV, Keet RPM et al. (1992.) HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 6, 49-54.
13. Merson MH (1993) Slowing the spread of HIV: agenda for the 1990s. Science 260, 1266-1268.
14. Myers G, Korber B, Wain-Hobson S, Smith RF & Pavlakis GM (eds) (1993) Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, N.M., III-69.
15. O'Brien WA, Koyanagi Y, Namazie A et al. (1990) HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature (London) 348, 69-73.
16. Okpara RA, Akinsete I, Williams EE et al. (1988) Antibodies to human immunodeficiency virus (HTLV-III/LAV) in people from Lagos and Cross River States of Nigeria. Acta Haematologica 79, 91-93.
17. Olaleye DO, Bernstein L, Ekweozor C et al. (1993) Prevalence of human immunodeficiency virus types 1 and 2 infections in Nigeria. Journal of Infectious Diseases 167, 710-714.
18. Olaleye DO, Ekweozor CC, Sheng Z & Rasheed S (1995) Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria. International Journal of Epidemiology 24, 198-203.
19. Rasheed S, Norman GL & Shu Su (1987) Acquired immunodeficiency syndrome: Diagnostic procedures for the antibody and retrovirus. In Viral Hepatitis and AIDS (ed. V.M. Villarejos), T. Hnos, pp. 31-52.
20. Roos MT, Lange JMA, De Goede REY et al. (1992.) Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. Journal of Infectious Diseases. 165, 427-432.
21. Shioda T, Levy JA & Cheng-Mayer C (1991) Macrophage and T-cell line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature (London) 349, 167-169.
22. Schuitemaker H, Koot M, Koostra NA et al. (1991) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. Journal of Virology 66, 1354-1360.
23. Tersmette M, Lange JMA, DeGoede REY et al. (1989A) Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet i, 983-985.
24. Tersmette M, Gruters RA, De Wolf F et al. (1989B) Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. Journal of Virology 63, 2118-2125.
25. Weiss RA (1993) How does HIV cause AIDS? Science 260, 1273-1279.
26. Wendler I, Schneider J, Gras B et al. (1986) Seroepidemiology of human immunodeficiency virus in Africa. British Medical Journal of Clinical Research 293, 782-785.
27. Westervelt PH, Gendelman HE & Ratner L (1991) Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proceedings of the National Academy of Sciences of the USA 88, 3097-3101.
28. Williams EE, Mohammed I, Chikwem J et al. (1990) HIV-1 and HIV-2 in Nigerian populations with high-and low-risk behavior patterns [letter] AIDS 4, 1041-1042.
29. World Health Organization (1993) Acquired immunodeficiency syndrome (AIDS)-data as of 30 June 1993. Weekly Epidemiological Record 27, 193-196.